Some of that return (to workplaces) depends on the effectiveness of the coronavirus vaccine, which currently is in short supply.
“It is possible the vaccine will be 80 to 90% effective, so we have another year of muddling through,” said Jon Carnegie, executive director of the Voorhees Transportation Center at Rutgers University.
“Starting in the fall, we might start to see experimentation of what the post-COVID normal might be,” he said. “Even with the vaccine, social distancing and things like that in offices will remain the norm for years to come.”